@article{ajmcr2017553,
author={{Palacio, Agustina C. and Cabrini, Mercedes and Ben, Graciela and Dodds, Emilio M.},
title={Rifabutin Low Dose-Induced Intermediate Uveitis in a Patient with Acquired Immunodeficiency Syndrome},
journal={American Journal of Medical Case Reports},
volume={5},
number={5},
pages={116--118},
year={2017},
url={http://pubs.sciepub.com/ajmcr/5/5/3},
issn={2374-216X},
abstract={Intermediate uveitis is a relatively rare manifestation of Rifabutin induced uveitis. Rifabutin toxicity is unusual at doses of 300 mg daily or less. The purpose of this study is to report the case of an HIV+ patient with unilateral rifabutin induced intermediate uveitis after 4 months of treatment with low dose rifabutin (150 mg daily) in combination with ritonavir and fluconazole. The uveitis resolved after drug discontinuance and the use topical corticosteroids.},
doi={10.12691/ajmcr-5-5-3}
publisher={Science and Education Publishing}
}